Pulmonary Arterial Hypertension Market
The Pulmonary Arterial Hypertension (PAH) market is a specialized segment of the pharmaceutical and healthcare industries, focusing on the treatment and management of pulmonary arterial hypertension. PAH is a rare but life-threatening condition characterized by high blood pressure in the arteries of the lungs, leading to strain on the heart...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian